1. Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation

   • Hsing-Chuan Tsai
   • May H. Han

   Leading Article 18 June 2016 Pages: 1067 - 1079

   

2. Targeting Select Cellular Stress Pathways to Prevent Hyperglycemia-Related Complications: Shifting the Paradigm

   • Arshag D. Mooradian

   Leading Article 30 June 2016 Pages: 1081 - 1091

   

3. Psychosis in Parkinson’s Disease: Epidemiology, Pathophysiology, and Management

   • Anna Chang
   • Susan H. Fox

   Review Article 16 June 2016 Pages: 1093 - 1118

4. Management of Myopic Choroidal Neovascularization: Focus on Anti-VEGF Therapy

   • Kelvin Yi Chong Teo
   • Wei Yan Ng
   • Chui Ming Gemmy Cheung

   Review Article 30 June 2016 Pages: 1119 - 1133

   

5. Secukinumab: A Review in Psoriatic Arthritis

   • Matt Shirley
   • Lesley J. Scott

   Adis Drug Evaluation 14 June 2016 Pages: 1135 - 1145

   

6. Migalastat: First Global Approval

   • Anthony Markham

   AdisInsight Report 28 June 2016 Pages: 1147 - 1152

   

7. Olmutinib: First Global Approval

   • Esther S. Kim

   AdisInsight Report 29 June 2016 Pages: 1153 - 1157

   

8. Erratum to: Reslizumab: First Global Approval

   • Anthony Markham

   Erratum 28 June 2016 Pages: 1159 - 1159